Marine Compounds and Cancer / / edited by Friedemann Honecker, Sergey A. Dyshlovoy.

The very first marine-derived anticancer drug, Cytarabine (aka Ara-C, Cytosar-U(R)), was approved by the FDA in 1969 for the treatment of leukemia. At the beginning of 2021, the list of approved marine-derived anticancer drugs consists of nine substances, five of which received approval within the l...

Full description

Saved in:
Bibliographic Details
TeilnehmendeR:
Place / Publishing House:Basel : : MDPI - Multidisciplinary Digital Publishing Institute,, 2018.
Year of Publication:2018
Language:English
Physical Description:1 online resource (v, 110 pages)
Tags: Add Tag
No Tags, Be the first to tag this record!
id 993561790204498
ctrlnum (CKB)4920000000094882
(NjHacI)994920000000094882
(EXLCZ)994920000000094882
collection bib_alma
record_format marc
spelling Marine Compounds and Cancer / edited by Friedemann Honecker, Sergey A. Dyshlovoy.
Basel : MDPI - Multidisciplinary Digital Publishing Institute, 2018.
1 online resource (v, 110 pages)
text txt rdacontent
computer c rdamedia
online resource cr rdacarrier
Description based on publisher supplied metadata and other sources.
The very first marine-derived anticancer drug, Cytarabine (aka Ara-C, Cytosar-U(R)), was approved by the FDA in 1969 for the treatment of leukemia. At the beginning of 2021, the list of approved marine-derived anticancer drugs consists of nine substances, five of which received approval within the last two years, demonstrating the rapid evolution of the field. The current book is a collection of scientific articles related to the exponentially growing field of anticancer marine compounds. These articles cover the whole field, from agents with cancer-preventive activity, to novel and previously characterized compounds with anticancer activity, both in vitro and in vivo, as well as the latest status of compounds under clinical development.
Cancer Radiotherapy.
Marine toxins.
3-03842-765-9
Honecker, Friedemann, editor.
Dyshlovoy, Sergey A., editor.
language English
format eBook
author2 Honecker, Friedemann,
Dyshlovoy, Sergey A.,
author_facet Honecker, Friedemann,
Dyshlovoy, Sergey A.,
author2_variant f h fh
s a d sa sad
author2_role TeilnehmendeR
TeilnehmendeR
title Marine Compounds and Cancer /
spellingShingle Marine Compounds and Cancer /
title_full Marine Compounds and Cancer / edited by Friedemann Honecker, Sergey A. Dyshlovoy.
title_fullStr Marine Compounds and Cancer / edited by Friedemann Honecker, Sergey A. Dyshlovoy.
title_full_unstemmed Marine Compounds and Cancer / edited by Friedemann Honecker, Sergey A. Dyshlovoy.
title_auth Marine Compounds and Cancer /
title_new Marine Compounds and Cancer /
title_sort marine compounds and cancer /
publisher MDPI - Multidisciplinary Digital Publishing Institute,
publishDate 2018
physical 1 online resource (v, 110 pages)
isbn 3-03842-765-9
callnumber-first Q - Science
callnumber-subject QP - Physiology
callnumber-label QP632
callnumber-sort QP 3632 M37 M375 42018
illustrated Not Illustrated
dewey-hundreds 600 - Technology
dewey-tens 610 - Medicine & health
dewey-ones 615 - Pharmacology & therapeutics
dewey-full 615.945
dewey-sort 3615.945
dewey-raw 615.945
dewey-search 615.945
work_keys_str_mv AT honeckerfriedemann marinecompoundsandcancer
AT dyshlovoysergeya marinecompoundsandcancer
status_str n
ids_txt_mv (CKB)4920000000094882
(NjHacI)994920000000094882
(EXLCZ)994920000000094882
carrierType_str_mv cr
is_hierarchy_title Marine Compounds and Cancer /
author2_original_writing_str_mv noLinkedField
noLinkedField
_version_ 1764989379046014976
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01761nam a2200301 i 4500</leader><controlfield tag="001">993561790204498</controlfield><controlfield tag="005">20230220214134.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr |||||||||||</controlfield><controlfield tag="008">230220s2018 sz o 000 0 eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)4920000000094882</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(NjHacI)994920000000094882</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)994920000000094882</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">NjHacI</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="c">NjHacl</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">QP632.M37</subfield><subfield code="b">.M375 2018</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">615.945</subfield><subfield code="2">23</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Marine Compounds and Cancer /</subfield><subfield code="c">edited by Friedemann Honecker, Sergey A. Dyshlovoy.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Basel :</subfield><subfield code="b">MDPI - Multidisciplinary Digital Publishing Institute,</subfield><subfield code="c">2018.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (v, 110 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on publisher supplied metadata and other sources.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The very first marine-derived anticancer drug, Cytarabine (aka Ara-C, Cytosar-U(R)), was approved by the FDA in 1969 for the treatment of leukemia. At the beginning of 2021, the list of approved marine-derived anticancer drugs consists of nine substances, five of which received approval within the last two years, demonstrating the rapid evolution of the field. The current book is a collection of scientific articles related to the exponentially growing field of anticancer marine compounds. These articles cover the whole field, from agents with cancer-preventive activity, to novel and previously characterized compounds with anticancer activity, both in vitro and in vivo, as well as the latest status of compounds under clinical development.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Cancer</subfield><subfield code="x">Radiotherapy.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Marine toxins.</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-03842-765-9</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Honecker, Friedemann,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Dyshlovoy, Sergey A.,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-03-01 00:24:22 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2019-11-10 04:18:40 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&amp;portfolio_pid=5337839820004498&amp;Force_direct=true</subfield><subfield code="Z">5337839820004498</subfield><subfield code="8">5337839820004498</subfield></datafield></record></collection>